ProstaGene Overview

  • Founded
  • 2010
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $27M
Latest Deal Amount

ProstaGene General Information

Description

Developer of a diagnostic test designed to distinguish benign from malignant prostate cancer. The company's prognostic test defines a group of patients with poor outcome based on a signature of gene expression in the patients prostate tumor and it also offers a platform for preclinical testing of therapies for metastatic prostate cancer, enabling patients to early detect and cure cancers.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Angel backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Social/Platform Software
Biotechnology
Parent Company
Primary Office
  • 100 Lancaster Avenue
  • Room 133
  • Wynnewood, PA 19096
  • United States
+1 (267) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ProstaGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 16-Nov-2018 $27M 00.00 0000 Completed Generating Revenue
2. Angel (individual) 17-Apr-2016 00000 00.00 Completed Generating Revenue
1. Angel (individual) 19-May-2015 $1M $1M Completed Generating Revenue
To view ProstaGene’s complete valuation and funding history, request access »

ProstaGene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a diagnostic test designed to distinguish benign from malignant prostate cancer. The company's prognostic t
Other Healthcare Technology Systems
Wynnewood, PA
00.00
000 0000-00-00
000000&0 00.00

00000000

quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00

00000000

on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit i
0000000000000
San Carlos, CA
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ProstaGene Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytImmune Sciences Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
000000000 00000000 Venture Capital-Backed San Carlos, CA 0 000.00 0000000000 0 000.00
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000000 000000 00 Venture Capital-Backed Louisville, KY 000.00 0000000000 000.00
00000000 Private Equity-Backed Holliston, MA 00 000.00 000000000 - 000.00
You’re viewing 5 of 9 competitors. Get the full list »

ProstaGene Executive Team (2)

Name Title Board Seat Contact Info
Richard Pestell Ph.D Founder, Board Member & Chief Executive Officer
To view ProstaGene’s complete executive team members history, request access »

ProstaGene Board Members (1)

Name Representing Role Since
Daniel Matthias ProstaGene Advisor,Board Member & Founding Investor 000 0000
To view ProstaGene’s complete board members history, request access »

ProstaGene Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Rebecca Matthias Angel (individual) Minority 000 0000 000000 0
Thomas Jefferson University University Minority 000 0000 000000 0
To view ProstaGene’s complete investors history, request access »